Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study

BACKGROUND: Statins inhibit proliferative signalling in oesophageal adenocarcinoma (OAC) and their use is associated with better survival in observational studies. The present study was undertaken to examine the feasibility of assessing adjuvant statin therapy in patients with operable OAC in a phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexandre, L., Clark, A. B., Walton, S., Lewis, M. P., Kumar, B., Cheong, E. C., Warren, H., Kadirkamanathan, S. S., Parsons, S. L., Dresner, S. M., Sims, E., Jones, M., Hammond, M., Flather, M., Loke, Y. K., Swart, A. M., Hart, A. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Randomized Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996637/
https://www.ncbi.nlm.nih.gov/pubmed/32011825
http://dx.doi.org/10.1002/bjs5.50239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996637/
https://www.ncbi.nlm.nih.gov/pubmed/32011825
http://dx.doi.org/10.1002/bjs5.50239

Ejemplares similares